Blonder Tongue Laboratories, Inc.
BDRL
$0.1249
-$0.0026-2.04%
Weiss Ratings | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | D- | |||
Rating Factors | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Fair | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.61 | |||
Price History | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 8.61% | |||
30-Day Total Return | 13.55% | |||
60-Day Total Return | 3.65% | |||
90-Day Total Return | -26.53% | |||
Year to Date Total Return | -26.53% | |||
1-Year Total Return | -39.84% | |||
2-Year Total Return | -85.17% | |||
3-Year Total Return | -89.59% | |||
5-Year Total Return | -89.59% | |||
52-Week High % Change | -58.87% | |||
52-Week Low % Change | 112.15% | |||
Price | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.31 | |||
52-Week Low Price | $0.06 | |||
52-Week Low Price (Date) | Oct 23, 2023 | |||
52-Week High Price (Date) | Feb 01, 2023 | |||
Valuation | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | $1.84M | |||
Enterprise Value | 12.57M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.22 | |||
Earnings Per Share Growth | 527.17% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.09 | |||
Price/Book (Q) | 1.58 | |||
Enterprise Value/Revenue (TTM) | 0.69 | |||
Price | $0.12 | |||
Enterprise Value/EBITDA (TTM) | -6.26 | |||
Enterprise Value/EBIT | -5.89 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 13.347M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 732 679 4000 | |||
Address | One Jake Brown Road Old Bridge, NJ 08857 | |||
Website | www.blondertongue.com | |||
Country | United States | |||
Year Founded | 1950 | |||
Profitability | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -11.76% | |||
Profit Margin | -16.12% | |||
Management Effectiveness | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -9.90% | |||
Return on Equity | -- | |||
Income Statement | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | $18.12M | |||
Total Revenue (TTM) | $18.12M | |||
Revenue Per Share | $1.36 | |||
Gross Profit (TTM) | $5.46M | |||
EBITDA (TTM) | -$2.01M | |||
EBIT (TTM) | -$2.13M | |||
Net Income (TTM) | -$2.92M | |||
Net Income Avl. to Common (TTM) | -$2.92M | |||
Total Revenue Growth (Q YOY) | 32.18% | |||
Earnings Growth (Q YOY) | 109.71% | |||
EPS Diluted (TTM) | -$0.22 | |||
EPS Diluted Growth (Q YOY) | 107.49% | |||
Balance Sheet | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | $79.00K | |||
Cash Per Share (Q) | $0.01 | |||
Total Current Assets (Q) | $7.97M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | $1.07M | |||
Current Ratio (Q) | 0.977 | |||
Book Value Per Share (Q) | $0.08 | |||
Total Assets (Q) | $15.01M | |||
Total Current Liabilities (Q) | $8.16M | |||
Total Debt (Q) | $10.80M | |||
Total Liabilities (Q) | $13.93M | |||
Total Common Equity (Q) | $1.07M | |||
Cash Flow | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -$55.00K | |||
Cash from Financing (TTM) | $1.24M | |||
Net Change in Cash (TTM) | -$195.00K | |||
Levered Free Cash Flow (TTM) | -$831.60K | |||
Cash from Operations (TTM) | -$1.38M | |||